The End of Trial-and-Error Treatments

By Nick van Terheyden aka Dr Nick, Principal, ECG Management Consulting

Twitter: @drnic1
Host of Healthcare Upside Down – #HCupsidedown

Ten years or so ago, “genotyping” and “genetics” became household terms, thanks in part to 23 and Me—a personal genomics and biotech company based in California. 23 and Me was not the first company to sequence genomes, but it was the first to offer a simple, affordable, direct-to-consumer model of genetic testing.

What unfolded subsequently left something of a bad taste in many people’s mouths, as the company has spent many years wrangling with the FDA and...